The Federal Government of Nigeria has officially launched seven indigenous herbal medicines designed to treat and manage ailments including cancers, hepatitis B, hypertension, peptic ulcer disease, and high cholesterol. The milestone, announced by the Nigeria Natural Medicine Development Agency (NNMDA), underscores the nation's push to harness local medicinal resources for affordable healthcare.
Government Backs Indigenous Healthcare Innovation
Speaking at the unveiling in Lagos, the Minister of Innovation, Science and Technology, Dr. Kingsley Udeh, emphasized that Nigeria possesses thousands of medicinal plants with enormous potential to address pressing health challenges if properly researched and commercialized. He noted that traditional medicine has served communities for centuries and pledged federal support to remove obstacles limiting the agency's growth.
Udeh announced plans to establish a Clinical Observational Research Centre at NNMDA's Lagos headquarters and promised to explore alternative funding sources beyond the 2027 budget. He also commended the agency for its research into treatments for malaria, sickle cell disease, diabetes, and erectile dysfunction.
Full List of the Seven Herbal Medicines
NNMDA Director-General, Prof. Martins Emeje, stated that advances in scientific research and standardization have strengthened confidence in herbal medicine by ensuring proper dosage, quality, and safety. The seven products unveiled include:
- Namdavir – for managing Hepatitis B virus.
- Namdacid – formulated for treating peptic ulcer disease.
- Turmegol – designed for prevention and management of colorectal, ovarian, and prostate cancers.
- Namdorol – developed to lower high cholesterol and support hypertension management.
- Namgor – a natural aphrodisiac.
- Zobo Tea – produced for hypertension management.
- Another indigenous herbal formulation as part of the agency's expanding natural medicine programme.
Promising Cancer-Fighting Potential
Emeje revealed that laboratory investigations indicate Turmegol has shown potential to slow cancer progression and eliminate early-stage cancer cells. He stressed the importance of continued scientific validation and expanded clinical research to fully realize the product's benefits.
Jobs, Research, and Global Partnerships
The NNMDA boss disclosed that one of the newly launched products could create as many as 3.5 million jobs when fully commercialized across its value chain. He urged the federal government to accelerate clinical trials by establishing the proposed Clinical Observational Research Centre, describing it as critical to advancing research and gaining wider acceptance for Nigeria's natural medicines.
India's Consul General in Lagos, Shri Kannan, called for stronger collaboration between Nigeria and India in traditional medicine, medicinal plant research, scientific validation, quality assurance, and biodiversity conservation. He noted that both countries possess centuries-old healing traditions and rich biodiversity that can be leveraged to develop innovative healthcare solutions while expanding economic opportunities.
NAFDAC Alert on Imported Medication
In a related development, the National Agency for Food and Drug Administration and Control (NAFDAC) issued a public health warning following the recall of nearly 90,000 bottles of Children’s Ibuprofen Oral Suspension in the United States over contamination concerns. The agency urged Nigerians, healthcare providers, and drug distributors to remain vigilant against the affected medication entering the Nigerian market, as reported by Legit.ng.
